265 companies

HLB Pep

Market Cap: ₩64.5b

A bio-venture company, engages in the manufacture and sale of peptide biomaterials and drug raw materials in South Korea and internationally.

A196300

₩6,940.00

7D

-4.7%

1Y

-41.8%

SCM Lifescience

Market Cap: ₩44.6b

Operates in the stem cell therapy, CMO, contract research and consulting, and cosmetic businesses.

A298060

₩1,130.00

7D

-8.4%

1Y

-46.3%

MedPacto

Market Cap: ₩147.4b

A drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea.

A235980

₩4,300.00

7D

-6.3%

1Y

-31.0%

Kangstem Biotech

Market Cap: ₩140.1b

A biopharmaceutical company, develops stem cell therapeutic products for rare and incurable diseases.

A217730

₩1,490.00

7D

-6.9%

1Y

-14.4%

Daesung Microbiological Labs

Market Cap: ₩29.0b

Manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea.

A036480

₩7,640.00

7D

-4.1%

1Y

-24.1%

Dongwha Pharm.Co.Ltd

Market Cap: ₩176.0b

Manufactures and sells pharmaceutical products in South Korea.

A000020

₩6,350.00

7D

-0.3%

1Y

-18.7%

APTOCROM

Market Cap: ₩72.2b

Distributes pharmaceutical products in South Korea.

A109960

₩327.00

7D

-9.4%

1Y

-38.9%

Xcell Therapeutics

Market Cap: ₩32.9b

Engages in the development and production of drugs for cell therapy.

A373110

₩3,005.00

7D

-8.2%

1Y

-63.1%

ViGenCell

Market Cap: ₩80.0b

Specializes in immune cell therapy.

A308080

₩3,910.00

7D

0%

1Y

4.4%

Ark Solutions

Market Cap: ₩68.9b

Engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally.

A203690

₩4,425.00

7D

0%

1Y

-63.6%

BNC Korea

Market Cap: ₩342.0b

Engages in the research and development, production, and sale of biomaterials for medicines in South Korea.

A256840

₩5,000.00

7D

-3.5%

1Y

-13.0%

Kyung Nam PharmLtd

Market Cap: ₩46.4b

Engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia.

A053950

₩594.00

7D

-3.6%

1Y

-24.6%

PharmGen Science

Market Cap: ₩82.3b

Engages in the research and development, production, and sale of pharmaceutical products in South Korea.

A004720

₩4,390.00

7D

-4.4%

1Y

-12.4%

Onconic Therapeutics

Market Cap: ₩584.2b

Engages in the research and development of anti-cancer therapy in South Korea.

A476060

₩52,800.00

7D

17.1%

1Y

n/a

Kwang Dong Pharmaceutical

Market Cap: ₩231.0b

Operates as a human healthcare provider in South Korea.

A009290

₩5,880.00

7D

-0.5%

1Y

-0.5%

GI Innovation

Market Cap: ₩1.1t

A bio-venture company, engages in the research and development of protein new drugs.

A358570

₩17,780.00

7D

-7.1%

1Y

60.0%

Shaperon

Market Cap: ₩80.6b

A clinical stage biotech company, develops novel inflammasome inhibitors targeting immune-mediated inflammatory disorders with high unmet medical needs and nanobody therapeutics.

A378800

₩2,675.00

7D

24.7%

1Y

-34.2%

Helixmith

Market Cap: ₩286.0b

Develops biologic and natural nutraceutical products.

A084990

₩6,210.00

7D

0.6%

1Y

78.7%

Quratis

Market Cap: ₩69.9b

Engages in developing vaccines in South Korea.

A348080

₩946.00

7D

-8.2%

1Y

2.4%

NeoImmuneTech

Market Cap: ₩74.4b

A clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics.

A950220

₩753.00

7D

-12.8%

1Y

-46.2%

Seoulin BioscienceLtd

Market Cap: ₩56.2b

A bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea.

A038070

₩6,520.00

7D

-3.4%

1Y

-13.2%

Korea Arlico PharmLtd

Market Cap: ₩62.8b

Engages in the researches and develops, produces, and sells medicines in South Korea.

A260660

₩4,100.00

7D

-7.2%

1Y

-1.2%

TechnologyLtd

Market Cap: ₩4.7b

Manufactures and distributes pharmaceutical raw materials, healthcare products, and cosmetics in South Korea.

A043090

₩380.00

7D

0%

1Y

-84.2%

Green Cross Holdings

Market Cap: ₩713.3b

Operates as a biotechnology company.

A005250

₩15,650.00

7D

-6.6%

1Y

0.4%

BCWORLD PHARM

Market Cap: ₩38.1b

Operates as a pharmaceutical company in South Korea.

A200780

₩4,510.00

7D

3.2%

1Y

-1.4%

GW VitekLTD

Market Cap: ₩53.9b

Engages in the development, manufacturing, and sale of bio-related antibodies and biotechnology solutions in Korea, the United States, Asia, Europe, and internationally.

A036180

₩577.00

7D

0%

1Y

-20.3%

NanoEntek

Market Cap: ₩111.7b

Engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

A039860

₩3,480.00

7D

-1.7%

1Y

7.4%

Tdspharm

Market Cap: ₩54.8b

Researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally.

A464280

₩9,910.00

7D

-2.9%

1Y

-52.1%

Kainos Medicine

Market Cap: ₩35.6b

Engages in research and development of various medicines for cancers, brain, and infectious diseases in South Korea and internationally.

A284620

₩1,087.00

7D

0%

1Y

-76.5%

ToolGen

Market Cap: ₩320.5b

A biotechnology company, focuses on the development of genome editing technology in South Korea.

A199800

₩37,350.00

7D

-0.1%

1Y

-33.1%

Peptron

Market Cap: ₩6.5t

Engages in the development of peptide-based medicines.

A087010

₩277,500.00

7D

-4.1%

1Y

418.7%

HLB PANAGENE

Market Cap: ₩76.4b

Develops products in the field of molecular diagnostics in South Korea.

A046210

₩1,694.00

7D

-0.3%

1Y

-46.7%

Jeil Pharma Holdings

Market Cap: ₩133.4b

Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.

A002620

₩8,690.00

7D

0.2%

1Y

-2.7%

GENINUS

Market Cap: ₩67.9b

A bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea.

A389030

₩2,035.00

7D

-1.2%

1Y

29.3%

Prestige BioPharma

Market Cap: ₩161.2b

A biopharmaceutical company, engages in the research and development and marketing of biosimilars, first-in-class antibody drugs, and vaccines.

A950210

₩13,410.00

7D

-8.7%

1Y

-4.1%

Kolon TissueGene

Market Cap: ₩3.9t

Develops cell therapies for orthopedic diseases and other unmet medical needs.

A950160

₩47,300.00

7D

4.9%

1Y

243.3%

Page 3 of 8